The Assessment of Drug Interactions and Safety of Administration with Regard to Special Population Groups by a Developed Computer Program
Diabetes mellitus is a chronic disease that occurs due to a deficit in the secretion of insulin, or due to inadequate insulin action. Taking into consideration that diabetes mellitus is a chronic disease, thus it is unavoidable that a large number of diabetics, aside from their diabetes medicine, will be using other medication, which can cause interactions between the two types of drugs when they are combined. The aim of this project is to create a computer program which will aid a pharmacist during the process of dispensing diabetes medication, enabling him to check possible drug interactions and the safety of using certain types of drugs when drug pharmacodynamics and pharmacokinetics may be altered. Using C# and the MVC pattern, a program was developed which allows the examination of interactions between different drugs. By choosing the drugs of interest, the designed computer program is able to recognize if the given drug combination is safe, dangerous, or if it requires caution during administration. The program is also able to evaluate if the given diabetes medication is safe to use in special populations where drug pharmacodynamics and pharmacokinetics are altered. The application provides information that is easily and instantly available which can have a significant impact whilst working in pharmacy where the pharmacist needs to quickly make a decision regarding the safety of administration of a certain drug.
KeywordsInsulins Oral antidiabetics Drug interactions Special populations C# The MVC pattern
Conflict of interest declaration
The authors whose names are listed immediately below certify that they have no affiliations with or involvement in any organization or entity with any financial interests (such as honoraria, educational grants, membership, employment, stock ownership or other equity interest), or non-financial interest (such as personal or professional relationship) in the subject matter or materials discussed in this work.
- 1.Chobain, A.V., Bakris, G.L., Black, H.R.: The seventh report of the join national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289 (2003)Google Scholar
- 2.Heljić, B., Dilić, M., Čengić, M., Čengić, F., Lončarević, N.: Diabetes mellitus-klinički aspekti, Jež, Sarajevo (2002)Google Scholar
- 3.International Diabetes Atlas: Diabetes by Region, 8th edn. [Online]. http://diabetesatlas.org/IDF_Diabetes_Atlas_8e_interactive_EN/. Access: 14.07.2018 (2007)
- 4.Strategija borbe protiv dijabetesa u FBiH 2014–2024: Federalno ministarstvo zdravstva (2014)Google Scholar
- 5.World Heakth Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus (1999)Google Scholar
- 6.Adler, A.I., Strattion, I.M., Neil, H.A.: Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes: prospective observational study. BJM 321, 412–419 (2000)Google Scholar
- 7.Popović, P.S., Heljić, B.: Vodič za dijabetes. Sarajevo: Klinički centar Banja Luka, Institut za naučnoistraživački rad i razvoj Kliničkog Centra Univerziteta u Sarajevu (2008)Google Scholar
- 8.Rang, H.P., Dale, M.M., Ritter, J.M., Moore, P.K.: Farmakologija - Prvo srpsko izdanje, 5th edn, p. 718. Belgrade, Data status (2005)Google Scholar